PDCD1 and neoplasm: Due to improved liposome uptake in the tumor microenvironment, the liposomal group showed a longer survival rate and smaller tumor size than the free anti-PD-1 group across three tumor models (H22, 4T1, and CT26), with statistically significant differences (p < 0.05) [168].